Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study is designed to determine whether LLG783 displays the clinical safety and efficacy profile, after multiple i.v. doses, to support further development in patients with PAD and intermittent claudication.
Epistemonikos ID: 3dcdd3021cec6fd3e67160afbf87725e3ad4454b
First added on: May 20, 2024